Literature DB >> 7081821

Opsonin-independent phagocytosis by human alveolar macrophages: augmentation by human plasma fibronectin.

J K Czop, S E McGowan, D M Center.   

Abstract

A trypsin-sensitive membrane recognition unit that mediates phagocytosis of particulate activators of the human alternative complement pathway is present on human alveolar macrophages. Fragmented human plasma fibronectin selected by affinity chromatography with a monoclonal antifibronectin antibody augments this capacity. These data suggest a nonimmune mechanism for the clearance of some microorganisms from the opsonin-deficient microenvironment of the lung in which the alveolar macrophage is the principal resident phagocyte.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081821     DOI: 10.1164/arrd.1982.125.5.607

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

1.  Extracellular matrix components in bronchoalveolar lavage fluid in quartz exposed rats.

Authors:  A Eklund; G Tornling; E Blaschke; T Curstedt
Journal:  Br J Ind Med       Date:  1991-11

2.  Phagocytosis of unopsonized zymosan particles by trypsin-sensitive and beta-glucan-inhibitable receptors on bone marrow-derived murine macrophages.

Authors:  J L Kadish; C C Choi; J K Czop
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte beta-glucan receptors.

Authors:  M J Janusz; K F Austen; J K Czop
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

4.  Enhancement of human monocyte beta-glucan receptors by glucocorticoids.

Authors:  J Kay; J K Czop
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

5.  Modifications of plasma fibronectin in cystic fibrosis patients.

Authors:  L Stanislawski; M Sorin
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 6.  Viral-bacterial synergistic interaction in respiratory disease.

Authors:  L A Babiuk; M J Lawman; H B Ohmann
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.